Pharma in brief image

Current directions in regulatory and intellectual property law in Canadian pharmaceutical cases

Global |  Publication |  April 2016

Pharma in Brief 2015 year in review pdf

Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:

  • regulatory matters;
  • patent validity and damages;
  • Patented Medicines (Notice of Compliance) Regulations proceedings; and
  • class actions.

In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.

Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)



Recent publications

london bridge

Publication

Essential Corporate News – Week ending December 2, 2022

On December 1, 2022 the Financial Reporting Council (FRC) published a policy paper which gives an overview of the FRC’s approach to competition in the audit market. It also covers recent developments with competition in the audit market and the FRC’s current competition policy work.

United Kingdom | December 02, 2022

Corporate governance
Business board room abstract

Publication

Fair Work Legislation Amendment (Secure Jobs, Better Pay) Bill 2022 becomes law

Australia | December 02, 2022

Employment and labor
Energy-oil-and-gas-plant-lng

Publication

EU and UK financial market related initiatives and the energy crisis

Both the EU and the UK have been fighting the energy crisis for a year. As the crisis has evolved both the UK and the EU have responded with measures designed to protect both consumers and businesses.

Global | December 01, 2022

Financial institutions
site search

Subscribe and stay up to date with the latest legal news, information and events...

Register now